arrow
T

Tyler M. Renner

national research council of canada
H指数:14
被引数:555

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice

Stark, F.C.; Akache, B.; Renner, T.M.; Agbayani, G.; Deschatelets, L.; Dudani, R.; Harrison, B.A.; Hemraz, U.D.; Regnier, S.; Stuible, M.; 等. 硫酸化乳糖基阿奇醇古菌体佐剂与非佐剂的SARS-CoV-2刺突蛋白加强疫苗在年轻和老年Balb/c小鼠中的免疫原性。Vaccines 2025, 13, 1257. [Google Scholar] [CrossRef]

2026-03-040
OAAI
Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA/LNP prime induces robust and balanced immune responses

异源与同源疫苗接种方案:在mRNA/LNP初始免疫后,经SLA(硫酸化乳糖基古藻醇)古菌体佐剂加强的SARS-CoV-2刺突蛋白能够诱导强效且平衡的免疫应答

Vaccine
IF3.5
2026-01-070
OAAI
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model

通过修饰SARS-CoV-2刺突蛋白亚单位疫苗的糖基化谱,可以改变小鼠模型中体液免疫应答的聚焦方向。

2025-04-110
OA
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
2023-08-237
OA
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
2023-04-145
OAAI
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters

以蛋白体为佐剂的SARS-CoV-2刺突蛋白为基础的疫苗鼻内预防接种在小鼠和仓鼠中具有免疫原性和有效性

2022-06-1318
OAAI
Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant

基于抵抗素三聚刺突抗原SmT1和SLA古细菌佐剂的免疫原性和有效SARS-CoV-2疫苗

2021-11-0831
OAAI
In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism

体外丙型肝炎病毒感染与肝脏胆碱代谢

2020-01-169
OAAI